Phase I, Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers
Phase of Trial: Phase I
Latest Information Update: 28 May 2015
At a glance
- Drugs Cx 611 (Primary)
- Indications Sepsis
- Focus Pharmacodynamics; Proof of concept
- Acronyms CELLULA
- Sponsors TiGenix
- 28 May 2015 Results published in a TiGenix media release.
- 28 May 2015 Results were published in a TiGenix media release.
- 02 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.